Seeking Alpha

Galena Biopharma (GALE) +7.8% premarket after saying studies of its NeuVax treatment continue to...

Galena Biopharma (GALE) +7.8% premarket after saying studies of its NeuVax treatment continue to demonstrate excellent safety and efficacy profiles.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)